BioShin Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
BioShin Limited - overview
Established
2019
Location
Shanghai, -, China
Primary Industry
Biotechnology
About
Founded in 2019 and based in Shanghai, China, BioShin Limited is a biopharmaceutical company. In September 2020, the firm raised a series A funding for USD 60 million. The company is affiliated with Biohaven Pharmaceutical Holding Company Ltd. The company's main products include drugs targeting neurological and neuropsychiatric disorders.
It has a calcitonin gene-related peptide (CGRP) receptor antagonist and glutamate modulator platform.
Current Investors
OrbiMed Advisors, HBM Partners, Suvretta Capital Management
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.